Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert Meersseman

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2013
Biochemical screening assays to identify HIV-1 integrase inhibitorsMarleen Clynhens, Alexandra Smets, Inge Vereycken, et al.
Proteins|November 5, 2004
Anchor profiles of HLA-specific peptides: analysis by a novel affinity scoring method and experimental validationJohan Desmet, Geert Meersseman, Nathalie Boutonnet, et al.
Melanoma Research|December 5, 2015
Applications for quantitative measurement of BRAF V600 mutant cell-free tumor DNA in the plasma of patients with metastatic melanomaMax Schreuer, Geert Meersseman, Sari van Den Herrewegen, et al.
Genome Research|January 7, 2004
High-throughput MALDI-TOF discovery of genomic sequence polymorphismsPatrick Stanssens, Marc Zabeau, Geert Meersseman, et al.
Journal of Translational Medicine|April 21, 2016
Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitorsMax Schreuer, Geert Meersseman, Sari Van Den Herrewegen, et al.
Journal of Virology|August 22, 2008
Resistance mutations in human immunodeficiency virus type 1 integrase selected with elvitegravir confer reduced susceptibility to a wide range of integrase inhibitorsOlivia Goethals, Reginald Clayton, Marcia Van Ginderen, et al.
The Journal of Infectious Diseases|June 2, 2016
Development, Evaluation, and Integration of a Quantitative Reverse-Transcription Polymerase Chain Reaction Diagnostic Test for Ebola Virus on a Molecular Diagnostics PlatformLieselotte Cnops, Peter Van den Eede, James Pettitt, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2013
Biochemical screening assays to identify HIV-1 integrase inhibitorsMarleen Clynhens, Alexandra Smets, Inge Vereycken, et al.
Proteins|November 5, 2004
Anchor profiles of HLA-specific peptides: analysis by a novel affinity scoring method and experimental validationJohan Desmet, Geert Meersseman, Nathalie Boutonnet, et al.
Melanoma Research|December 5, 2015
Applications for quantitative measurement of BRAF V600 mutant cell-free tumor DNA in the plasma of patients with metastatic melanomaMax Schreuer, Geert Meersseman, Sari van Den Herrewegen, et al.
Genome Research|January 7, 2004
High-throughput MALDI-TOF discovery of genomic sequence polymorphismsPatrick Stanssens, Marc Zabeau, Geert Meersseman, et al.
Journal of Translational Medicine|April 21, 2016
Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitorsMax Schreuer, Geert Meersseman, Sari Van Den Herrewegen, et al.
Journal of Virology|August 22, 2008
Resistance mutations in human immunodeficiency virus type 1 integrase selected with elvitegravir confer reduced susceptibility to a wide range of integrase inhibitorsOlivia Goethals, Reginald Clayton, Marcia Van Ginderen, et al.
The Journal of Infectious Diseases|June 2, 2016
Development, Evaluation, and Integration of a Quantitative Reverse-Transcription Polymerase Chain Reaction Diagnostic Test for Ebola Virus on a Molecular Diagnostics PlatformLieselotte Cnops, Peter Van den Eede, James Pettitt, et al.
Pageof 1